U.S. markets closed
View all reports

Intellia Therapeutics, Inc. (NTLA) stock forecast and price target

Find the latest Intellia Therapeutics, Inc. NTLA analyst stock forecast, price target, and recommendation trends with in-depth analysis from research reports.

Date Range
investment rating
report type
sector
provider
NTLAIntellia Therapeutics, Inc.
66.36-0.33 (-0.49%)
At close: 4:00PM EDT

Recommendation Rating

2.1

Analyst Price Targets (13)

Current 66.36
Average 86.69
Low 60.00
High 115.00
Related Research Reports0 results
No reports found with the selected filters
Please update your filters to find matching research